Medicine and Dentistry
Chronic Kidney Disease
100%
Pediatrics
63%
Anemia
35%
Glomerular Filtration Rate
30%
Focal Segmental Glomerulosclerosis
28%
Nephrotic Syndrome
27%
End Stage Renal Disease
24%
Nephropathy
24%
Proteinuria
21%
Glomerulopathy
20%
Hepcidin
19%
Adolescent
18%
Amnioinfusion
17%
Fetal Therapy
17%
Vitamin D
16%
Pediatric Nephrology
15%
Cohort Analysis
15%
Disease
15%
Disease Exacerbation
14%
Renal Replacement Therapy
14%
Supplementation
14%
Minimal Change Disease
14%
Blood Pressure
12%
Transplantation
12%
Lupus Nephritis
12%
Peritoneal Dialysis
10%
Transcriptomics
9%
Erythropoietin
9%
Kidney Transplantation
9%
Systemic Lupus Erythematosus
8%
Clinical Trial
8%
Hematinic
8%
Renal Agenesis
8%
Nephrology
8%
Disease Severity
8%
Odds Ratio
8%
Cross Sectional Study
7%
Renal Biopsy
7%
Apolipoprotein L1
7%
Patient-Reported Outcome
7%
Cannabis Use
7%
Creatinine
7%
Quality of Life
6%
First Trimester Pregnancy
6%
Kidney Graft
6%
Biopsy
6%
Pulmonary Hypoplasia
6%
Colecalciferol
6%
Lupus Erythematosus
5%
Nephritic Syndrome
5%
Keyphrases
Chronic Kidney Disease
46%
Older Adults
27%
Chronic Kidney Disease in children
25%
Nephrotic Syndrome
23%
Focal Segmental Glomerulosclerosis
23%
Child Study
21%
Hemoglobin
19%
Anemia
17%
Dialysis
17%
Fetal Therapy
16%
Amnioinfusion
16%
Pediatric Chronic Kidney Disease
15%
Anhydramnios
15%
Estimated Glomerular Filtration Rate
14%
North America
14%
Pediatric
13%
Glomerular Disease
12%
Hepcidin
12%
Pediatric Nephrology
12%
End-stage Renal Disease
11%
Marijuana
11%
Alcohol
11%
Cigarette
11%
Electronic Cigarettes
11%
Cigarette Use
11%
Proteinuria
11%
Kidney Disease Progression
10%
Erythropoiesis-stimulating Agents
10%
Vitamin D Supplementation
9%
Minimal Change Disease
9%
Clinical Performance Measures
8%
Hispanic
8%
Renal Replacement Therapy
8%
Disease Severity
8%
Study within a Trial
8%
Collaborative Study
8%
Bilateral Renal Agenesis
8%
Clinical Outcomes
8%
Apolipoprotein L1 (APOL1)
7%
Therapy Outcome
7%
Scholarly Concentration
7%
Lupus Nephritis
7%
Medical Students
7%
Longitudinal Relationship
7%
Non-Hispanic White
7%
Transplant Outcomes
7%
Persistent Proteinuria
7%
Cholecalciferol Supplementation
6%
Dialysis Initiation
6%
Glomerular Filtration Rate
6%